These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 10446993)
21. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1. Vigneron A; Roninson IB; Gamelin E; Coqueret O Cancer Res; 2005 Oct; 65(19):8927-35. PubMed ID: 16204065 [TBL] [Abstract][Full Text] [Related]
22. Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells. Chiu CC; Li CH; Ung MW; Fuh TS; Chen WL; Fang K Cancer Lett; 2005 Jun; 223(2):249-58. PubMed ID: 15896459 [TBL] [Abstract][Full Text] [Related]
23. Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status. Bartussek C; Naumann U; Weller M Exp Cell Res; 1999 Dec; 253(2):432-9. PubMed ID: 10585266 [TBL] [Abstract][Full Text] [Related]
24. Microencapsulated tumor assay: new short-term assay for in vivo evaluation of the effects of anticancer drugs on human tumor cell lines. Gorelik E; Ovejera A; Shoemaker R; Jarvis A; Alley M; Duff R; Mayo J; Herberman R; Boyd M Cancer Res; 1987 Nov; 47(21):5739-47. PubMed ID: 3664478 [TBL] [Abstract][Full Text] [Related]
25. Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoids. Roninson IB; Dokmanovic M J Cell Biochem; 2003 Jan; 88(1):83-94. PubMed ID: 12461777 [TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352 [TBL] [Abstract][Full Text] [Related]
27. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Ota H; Tokunaga E; Chang K; Hikasa M; Iijima K; Eto M; Kozaki K; Akishita M; Ouchi Y; Kaneki M Oncogene; 2006 Jan; 25(2):176-85. PubMed ID: 16170353 [TBL] [Abstract][Full Text] [Related]
28. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cox ME; Deeble PD; Lakhani S; Parsons SJ Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001 [TBL] [Abstract][Full Text] [Related]
29. Growth factors and chemotherapeutic modulation of breast cancer cells. Ciftci K; Su J; Trovitch PB J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904 [TBL] [Abstract][Full Text] [Related]
30. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo. Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451 [TBL] [Abstract][Full Text] [Related]
31. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells. Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells. Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750 [TBL] [Abstract][Full Text] [Related]
33. Tumor initiating potential of side population cells in human gastric cancer. Fukuda K; Saikawa Y; Ohashi M; Kumagai K; Kitajima M; Okano H; Matsuzaki Y; Kitagawa Y Int J Oncol; 2009 May; 34(5):1201-7. PubMed ID: 19360333 [TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity, DNA strand breakage and DNA-protein crosslinking by a novel transplatinum compound in human A2780 ovarian and MCF-7 breast carcinoma cells. Farrell N; Povirk LF; Dange Y; DeMasters G; Gupta MS; Kohlhagen G; Khan QA; Pommier Y; Gewirtz DA Biochem Pharmacol; 2004 Sep; 68(5):857-66. PubMed ID: 15294448 [TBL] [Abstract][Full Text] [Related]
35. [Screening test of antitumor agents by human tumor cell lines in nude mice in ascitic form]. Kitahara T; Minato K; Shimoyama M Gan No Rinsho; 1984 Jul; 30(9 Suppl):1158-67. PubMed ID: 6590878 [TBL] [Abstract][Full Text] [Related]
36. Optimization of treatment conditions for studying the anticancer effects of retinoids using pancreatic adenocarcinoma as a model. El-Metwally TH; Adrian TE Biochem Biophys Res Commun; 1999 Apr; 257(2):596-603. PubMed ID: 10198257 [TBL] [Abstract][Full Text] [Related]
37. [The differentiation-inducing effect of tanshinone and retinoic acid on human cervical carcinoma cell line in vitro]. Yuan S; Huang G; Wang X Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):422-4. PubMed ID: 8697992 [TBL] [Abstract][Full Text] [Related]
38. Antiproliferative activity of an aqueous mistletoe extract in human tumor cell lines and xenografts in vitro. Burger AM; Mengs U; Schüler JB; Fiebig HH Arzneimittelforschung; 2001 Sep; 51(9):748-57. PubMed ID: 11642008 [TBL] [Abstract][Full Text] [Related]
39. In vitro evaluation of the anticancer drug modulatory effect of hyaluronidase in human gastrointestinal cell lines. Scheithauer W; Temsch EM; Stefenelli T; Lathan B Anticancer Res; 1988; 8(3):391-5. PubMed ID: 3389743 [TBL] [Abstract][Full Text] [Related]
40. Chemoresistant cell lines: morphonuclear characteristics and chemosensitivity development during long-term culture. Pauwels O; Kiss R Anticancer Res; 1993; 13(5A):1593-9. PubMed ID: 8239539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]